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Abstract
Adequate folate and iron intake during pregnancy is critical for maternal and fetal health. No 
previous studies to our knowledge have reported dietary supplement use and folate status among 
pregnant women sampled in NHANES, a nationally representative, cross-sectional survey. We 
analyzed data on 1296 pregnant women who participated in NHANES from 1999 to 2006 to 
characterize overall supplement use, iron and folic acid use, and RBC folate status. The majority 
of pregnant women (77%) reported use of a supplement in the previous 30 d, most frequently a 
multivitamin/-mineral containing folic acid (mean 817 μg/d) and iron (48 mg/d). Approximately 
55–60% of women in their first trimester reported taking a folic acid- or iron-containing 
supplement compared with 76–78% in their second trimester and 89% in their third trimester. 
RBC folate was lowest in the first trimester and differed by supplement use across all trimesters. 
Median RBC folate was 1628 nmol/L among users and 1041 nmol/L among nonusers. Among all 
pregnant women, median RBC folate increased with trimester (1256 nmol/L in the first, 1527 
nmol/L in the second, and 1773 nmol/L in the third). Given the role of folic acid in the prevention 
of neural tube defects, it is notable that supplement use and median RBC folate was lowest in the 
first trimester of pregnancy, with 55% of women taking a supplement containing folic acid. Future 
research is needed to determine the reasons for low compliance with supplement 
recommendations, particularly folic acid, in early pregnancy.
Introduction
Micronutrient needs increase during pregnancy due to changes in physiology and 
homeostatic control (1,2). Although increased nutrient intake should preferably come from 
food sources, even within the developed world it may be unlikely that pregnant and child-
bearing–age women meet their needs for micronutrients, such as iron and calcium, through 
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foods alone (2,3). However, the extent of potential nutrient deficiency during pregnancy 
may vary by demographic characteristics, such as younger maternal age and lower income 
and education (1,4). Although general multivitamin supplement use during pregnancy is not 
formally recommended, clinicians routinely recommend or prescribe prenatal vitamins to 
potentially compensate for dietary shortfalls (5). However, supplementation with folic acid 
and iron specifically, either before or during pregnancy, is recommended by several health 
organizations (1,4–8). In addition to supplementation, the U.S. food supply was fortified 
with folic acid beginning in 1997 to target reproductive-aged females in order to reduce the 
incidence of neural tube defects (9). Despite this fortification, women of child-bearing age 
still have usual folic acid intakes below the recommendations (10,11).
Although prenatal vitamin and mineral supplements are widely recommended as a standard 
of care in clinical practice, little is known about the national prevalence of supplement use 
during pregnancy and the characteristics of pregnant women who take dietary supplements. 
In addition, folic acid and iron supplement use and folate status have not, to our knowledge, 
been examined among a nationally representative sample of pregnant women in the US. 
Previous studies of dietary supplement use in pregnancy using national data are now 
outdated because of changes in folic acid awareness and fortification (12,13), are specific to 
only one micronutrient (14), or are not specific beyond multivitamin use (15). Therefore, the 
purpose of this analysis is to describe the prevalence and correlates of dietary supplement 
use as well as iron and folic acid supplement use and to describe RBC folate status during 
pregnancy using data from the NHANES (1999–2006).
Subjects and Methods
We used data from the 1999–2006 NHANES for this analysis. NHANES is a nationally 
representative, cross-sectional sample of the U.S. civilian, noninstitutionalized population 
administered by the National Center for Health Statistics (16). Since 1999, NHANES has 
been operated as a continuous survey and includes a household interview component 
followed by a physical examination in the mobile examination center (MEC)6. During the 
1999–2006 NHANES, response rates for the household interview averaged 81% and 
averaged 77% for the MEC exam. During this same period, NHANES oversampled 
pregnant women (17). This analysis of secondary data was not subject to institutional review 
by any of the participating organizations.
Pregnancy status for NHANES participants is assessed during both the household interview 
and the MEC examination. In addition to being asked about current pregnancy status at the 
time of the household screening, women ages 8–59 y who were examined in the MEC were 
also given a urine pregnancy test before undergoing an examination (17). Only women who 
were seen in the MEC were included in this analysis. In addition, questions about currently 
being pregnant and month of pregnancy were asked during the MEC examination as part of 
the reproductive health questionnaire (RHQ) (18). From 1999 to 2006, we initially identified 
1274 women who were pregnant at the time of their MEC participation according to the 
RIDEXPRG variable, which indicates pregnancy status in NHANES. Twenty-two additional 
6Abbreviations used: MEC, mobile examination center; PIR, poverty income ratio; RHQ, reproductive history questionnaire.
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women had a missing pregnancy status according to the RIDEXPRG variable but stated they 
were currently pregnant and had information on month of pregnancy in the RHQ. We 
therefore reassigned their status to “pregnant,” resulting in 1296 pregnant women available 
for analysis. Of these, all women had data on dietary supplement use.
Supplement use, folate status, and covariates
Dietary supplement use was assessed as part of the household interview for all NHANES 
participants. Survey participants were asked to complete the dietary supplement 
questionnaire that examines use of dietary supplements in the previous 30 d. If a person 
reported use of supplements, they were asked to provide the container and/or label of the 
products, which were then quantified and verified by survey personnel through examination 
of the supplement labels or by otherwise obtaining information from the supplement 
manufacturers (19). In the NHANES dietary supplement data, antacid use is considered 
separately from other dietary supplement use. If a pregnant woman answered “no” to the 
question regarding dietary supplement use but “yes” to the question on antacid use, she was 
not counted in this analysis as a dietary supplement user. This was done to avoid over-
representing true dietary supplement use by including women who might have used antacids 
only for medicinal purposes (e.g., to relieve heartburn) instead of to obtain minerals such as 
calcium and magnesium, which antacids commonly contain. Because of this, if a pregnant 
respondent answered “yes” to the dietary supplement question and reported taking antacids 
in addition to other supplements, the antacids were included and analyzed as their own 
group to distinguish them from other mineral supplements.
For the more general analysis on supplement intake, we classified supplements according to 
the following categories: 1) combined multivitamin/-mineral: supplement containing mainly 
both vitamins and minerals; 2) single or multivitamin: supplement contains one or more 
vitamins with no minerals; 3) single or multimineral: supplement contains one or more 
minerals with no vitamins and is not otherwise classified as an antacid; 4) botanical/herbal/
other: supplement contains mainly botanical or other non-vitamin or mineral ingredients; 5) 
antacid: supplement may contain multiple minerals but is classified as an antacid; and 6) 
unknown: supplement reported but name and ingredients were unknown. The categories of 
herbal/botanical/other and unknown had too few reported to make reliable estimates and 
therefore results are not shown. For the specific folic acid and iron supplement intake 
analysis, we identified supplements by their inclusion of folic acid or iron as noted by their 
respective ingredient identification codes on the appropriate dietary supplement analytic file.
We examined RBC folate (nmol/L), which is collected and analyzed as part of the standard 
venipuncture performed during the MEC examination (20). For all the years included in this 
analysis, we measured serum and RBC folate using the Bio-Rad Laboratories assay; 
however, it has been shown that this assay underestimates RBC folate when compared to the 
gold-standard microbiological assay (21). Therefore, we adjusted RBC folate values using 
regression equations as recommended by the National Center for Health Statistics (22). Data 
on RBC folate were missing for 92 (7.1%) of pregnant women. We examined only RBC 
folate in this analysis, because it is a better indicator of long-term folate storage than serum 
folate and not subject to hemodilution that occurs during pregnancy (23).
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Covariates of interest included age (<25, ≥25 y), race/ethnicity (non-Hispanic white, non-
Hispanic black, Mexican-American, and other, including other Hispanic), marital status 
(married or unmarried), education (high school graduate or less, some college or more), 
parity (first pregnancy or second or greater pregnancy), trimester of pregnancy coded 
according to the month of pregnancy reported by the respondent on the RHQ, health 
insurance coverage status, and socioeconomic status. Socioeconomic status was assessed 
using poverty income ratio (PIR), which is the ratio of income to the appropriate poverty 
threshold, developed and updated regularly by the U.S. Census Bureau (24). A ratio of <1 
designates a family or individual as being “poor” or falling below the federal poverty 
threshold. For the current analysis, the PIR was categorized as poor (<1), near-poor (1 to 
<2), and not poor (≥2).
Statistical analysis
Weighted frequencies of the socio-demographic characteristics were examined for pregnant 
women taking and not taking supplements. Percentages and SEs were estimated using 
PROC DESCRIPT in SUDAAN (25). We present results in text as percentages ± SE. 
Significant differences in percentages within variable categories were assessed using 
pairwise comparisons generated by the PRED_EFF statement in PROC RLOGIST at the P < 
0.05 level (25). Because supplement use was highly prevalent in these data, resulting in ORs 
substantially higher than the RR, we calculated model-adjusted prevalence ratios and 95% 
CIs for each covariate using the PREDMARG statement in PROC RLOGIST (26). Model-
adjusted methods were used to further examine these associations after adjusting for the 
effect of the other variables and determining the most parsimonious model. The logistic 
regression models do not include missing data. We also estimated the percent of pregnant 
women reporting dietary supplement use according to the broader categories of supplements 
and specifically folic acid and iron using PROC SURVEYFREQ in SAS (27). The mean 
intake of folic acid and iron intake via dietary supplements (mean ± SE) was calculated 
using an algorithm and program provided by National Center for Health Statistics (28). 
Mean and percentiles of RBC folate were estimated according to supplement use and 
trimester of pregnancy using PROC DESCRIPT. All results were weighted using the MEC 
examination weights, which were combined and recalculated for all years of NHANES used 
in analysis per NHANES guidance (29).
Results
Of pregnant women, 78% ± 2 reported supplement use in the previous 30 d (Table 1). 
Pregnant women using supplements differed from women not using supplements by nearly 
every characteristic. Compared with those not taking supplements, pregnant women 
reporting supplement use were more likely to be 25 y of age or older, have at least some 
college education, and were more likely to be non-Hispanic white. Eighteen percent of 
supplement users were unmarried compared with 47% among supplement nonusers. 
Pregnant women who reported supplement use were more likely to be in their third 
trimester, whereas women reporting no supplement use were more likely in their first 
trimester. Whereas most supplement users and nonusers had some type of health insurance, 
nonusers were more likely to be uninsured than women who reported supplement use. 
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Finally, pregnant women reporting supplement use were more likely to have a PIR of ≥2 
(indicating higher income) compared with those not taking supplements.
In the crude bivariate analysis (Table 2), significant associations supported the results 
shown in Table 1. Due to the correlation among education, income, and health insurance, 
only education was included in the adjusted model, along with the other demographic 
characteristics. Education was selected due to its previously shown association with 
nutritional habits (30). Health insurance was then added to this model to assess whether it 
had an additional impact on the correlates of supplement use; however, addition of insurance 
did not change the model fit or substantially alter the associations with the other correlates. 
The results of that model are shown in Table 2. Addition of income did not change model fit 
and is not presented here. After adjusting for all variables, except income, only trimester and 
education were significantly associated with supplement use.
The majority of pregnant women reported taking a multivitamin/mineral (Table 3). In 
addition, 74% reported taking a supplement, either a multivitamin or multimineral 
containing folic acid, and 73% reported taking an iron-containing supplement. Most 
pregnant women reporting supplement use reported taking only one supplement (72% ± 3), 
but values ranged from 1 to 12 with a mean of 1.4 ± 0.1. We examined and compared the 
characteristics of women reporting folic acid and iron supplementation with those not 
reporting use, but the results were very similar to those of supplement use overall and are 
not reported here.
Finally, we examined the percent of women taking iron and folic acid by trimester of 
pregnancy (Table 4) and percentiles of RBC folate by supplement use and trimester (Table 
5). Approximately 55–60% of women in their first trimester reported taking a folic acid- or 
iron-containing supplement compared with 76–78% in their second trimester and 89% in 
their third trimester. In general, RBC folate was lower among supplement nonusers and 
lowest among women in their first trimester.
Discussion
The majority of pregnant women in the US are using a dietary supplement at some time 
during their pregnancy, most frequently a multivitamin/-mineral product. However, ~20% 
reported not using a dietary supplement during pregnancy, although this may vary by 
trimester; women in their third trimester of pregnancy were more likely to report using 
supplements compared with women in their first trimester. In addition, use of supplements 
in pregnancy was related to education, income, health insurance status, age, race/ethnicity, 
and marital status similar to findings in other life-stage groups and other reports (15,17). 
However, after multivariate adjustment, only education and trimester of pregnancy were 
significantly associated with supplement use during pregnancy in the US. We also found 
that the majority of pregnant women were taking a supplement containing folic acid and/or 
iron and that supplement use was associated with improved RBC folate status. Finally, RBC 
folate status varied by trimester, indicating potential shortfalls in folic acid intake in early 
pregnancy even during an era of increased awareness of folic acid use in pregnancy and 
fortification of the food supply.
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To our knowledge, only one previous study has examined iron supplement use among a 
nationally representative sample of pregnant women in the US. Using NHANES III (1988–
1994), Cogswell et al. (14) reported that 72% of pregnant women sampled reported taking a 
dietary supplement containing iron. Although the unweighted sample size (n = 295) was less 
than in the current study, our results of 73% closely match. However, this may indicate that 
iron supplementation has not improved among pregnant women in the US in the last decade. 
In addition, we report a lower mean intake of iron from supplements (48 mg/d) compared 
with the 78 mg/d that Cogswell et al. (14) reported. The reason for this difference is not 
clear, although the estimates from the current study are more closely aligned with the 
Tolerable Upper Intake Limit for iron of 45 mg/d (31). A recent analysis using the same 
NHANES sample as the current study reported that the overall prevalence of iron deficiency 
was 18% among pregnant women, which still exceeds the Healthy People 2010 baseline 
measure of 16% and the target goal of 14.5% iron deficiency during pregnancy (32,33). This 
indicates that more strides may need to be made to improve iron supplementation to help 
reduce iron deficiency during pregnancy.
We are not aware of any other study that reported findings on the prevalence of folic acid 
supplementation or folate status among a nationally representative sample of pregnant 
women in the US, although studies have reported on folate status and folic acid intake 
among nonpregnant women using NHANES data (11,34,35). An analysis of women of 
childbearing age sampled in the 2001–2002 NHANES revealed low intake of folic acid via 
supplementation (26% of women 15–49 y old taking >400 μg/d) (11). Similarly, an analysis 
of folic acid intake from supplements and foods from the 2003–2006 NHANES 
demonstrated that only 24% of nonpregnant women overall consumed the recommended 
400 μg/d (34); however, when stratified by supplement use, 72% of women reporting 
supplement use were found to consume 400 μg/d folic acid, thus illustrating the role 
supplements play in helping women obtain the recommended daily amount. In addition, 
studies have shown that dietary supplement users have better dietary quality, including 
higher fruit and vegetable consumption, and have higher folic acid intakes from food alone 
compared with supplement nonusers (36,37); therefore, the pregnant women reporting 
supplement use in this sample could also be obtaining the recommended amount of folic 
acid due to improved diets as well. Although we did not assess dietary intake of this group 
of pregnant women, future research could determine if there are differences in dietary 
quality associated with supplement use during pregnancy.
Our results also demonstrate that folic acid supplement use was associated with improved 
folate status, similar to a recent population-based study of Canadian women (38). In that 
study, Colapinto et al. (39) reported that for supplement nonusers, at least 25% of pregnant 
women did not have RBC folate concentrations >906 nmol/L, which is one cutoff value that 
has been defined to prevent neural tube defects. Our results showed that among all pregnant 
women, the 25th percentile value of 953 nmol/L for women in their first trimester was not 
much above this particular cutoff value. We found that the RBC folate concentration was 
lowest during the first trimester, a time when folic acid is critical; however, the median RBC 
folate in the first trimester was still greater among the pregnant supplement takers in our 
study compared with nonpregnant women ages 15–44 y from NHANES 1999–2010 as 
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reported by Pfeiffer et al. (40). In addition, the majority of folic acid supplements reported in 
this analysis contained higher dosages of folic acid (≥800 μg), which indicates that most 
women were taking prenatal doses of folic acid rather than the lower standard multivitamin 
dosages (400 μg). Small numbers did not permit us to conduct a more formal analysis by 
folic acid dose by trimester. Although we report a mean daily folic acid intake from 
supplements of double the recommended amount and that 72% of pregnant women reported 
taking a folic-acid supplement, we were not able to assess when women began using folic 
acid. However, folic acid supplementation, as well as overall dietary supplement use, was 
lowest in the first trimester of pregnancy, a finding not explained by sociodemographic 
characteristics.
Although multivitamin and folic acid supplementation is recommended during early 
pregnancy, these findings could reflect the difficulties some women encounter with 
tolerance of supplementation, particularly iron supplements, due to nausea and vomiting in 
early pregnancy (41,42). In addition, it is possible that women who were sampled while in 
their first trimester may have recently become aware of their pregnancy and therefore were 
not taking supplements. However, because folic acid is recommended prior to pregnancy for 
women of child-bearing age, this may also corroborate the low compliance of these 
recommendations as reported by Yang et al. (11). More research is needed on the potential 
for lower-than-recommended nutrient intakes, particularly in early pregnancy, and to 
determine the reasons for noncompliance in early pregnancy.
It is important to note, however, that the pregnant women in NHANES were not evenly 
distributed by trimester. Of the women with data on month of current pregnancy (81% of 
women coded as pregnant), 20% were in the first trimester, with 41 and 38% in the second 
and third trimesters, respectively (unweighted and weighted data yielded similar 
distributions). Women who were missing data on trimester were similar to all pregnant 
women in NHANES, with respect to race/ethnicity, education, and marital status, and ~72% 
of women missing information on trimester reported taking supplements; however, it is 
possible that some bias may have been incurred by this unequal distribution of pregnancy by 
trimester. We did perform a sensitivity analysis to try to assess this potential bias where all 
pregnant women missing information on month of pregnancy were reassigned to the first 
trimester group and the data were reanalyzed. Although this resulted in a more even 
distribution of women by trimester among supplement users, it did not change the results of 
the percent of pregnant women taking supplements by trimester or the logistic regression.
In the current study, education was associated with supplement use in pregnancy, which is 
similar to findings from studies of multivitamin use in the general population using 
NHANES data (43,44). In addition, education as well as age and race/ethnicity is associated 
with intention to be become pregnant, which in turn is associated with multivitamin and 
folic acid use (45,46). Though this could help explain the findings related to education, 
information on intention of pregnancy is not available in NHANES. Further research is 
needed to understand potential interactions between intention of pregnancy and 
demographic characteristics as they relate to multivitamin and dietary supplement use.
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Our study relies upon self-reported interview data; however, NHANES interviewers ask to 
see the dietary supplement containers that each participant reports using to verify the 
reported supplements. Furthermore, although we had a nationally representative sample, the 
unweighted sample sizes were too small to perform more stratified analyses by supplement 
type and examine potential interactions (e.g., race/ethnicity by education). We were not able 
to assess other potential factors related to dietary supplement use in pregnancy, such as 
pregnancy intention. Furthermore, physiological changes in pregnancy may alter RBC folate 
concentrations. With these caveats in mind, the strengths of our study should not be 
overlooked. This study documents supplement use and is the first to our knowledge to 
examine folate status in pregnancy in a nationally representative population of pregnant 
women who were sampled at different times throughout pregnancy. The detailed 
information on supplement use allowed us to explore dietary supplements beyond 
multivitamins and minerals among a nationally representative group of pregnant women, 
which to the best of our knowledge, has not been previously done.
Although the majority of U.S. pregnant women appear to be taking a dietary supplement 
during pregnancy, ~20% are not. While young women, those of race/ethnicity other than 
non-Hispanic white, and/or those who have less education are at potential risk for nutritional 
deficiencies in pregnancy, more research is needed to understand why supplement use may 
still be low in early pregnancy. In addition, the results of this analysis suggest that the 
desired compliance with folic acid supplement recommendations for women of child-
bearing age are still not being fully met, as indicated by relatively low RBC folate status of 
women in early pregnancy.
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TABLE 1
Characteristics of supplement users and nonusers among pregnant women in NHANES 1999–2006
Supplement users, n = 1007 Supplement nonusers, n = 289 Chi-square P value
n
weighted % 1 n weighted %
All pregnant women 1007 77.6 ± 2.2 289 22.4 ± 2.2 <0.0001
Age
    <25 y 364 28.3 ± 2.7 181 56.7 ± 5.3 <0.0001
    ≥25 y 643 71.7 ± 2.7 108 43.2 ± 5.3
Race/ethnicity
    Non-Hispanic white 508 62.5 ± 2.7 54 27.7 ± 5.7 <0.0001
    Non-Hispanic black 129 12.3 ± 1.5 78 27.0 ± 4.6
    Mexican-American 266 11.7 ± 1.4 125 23.6 ± 3.7
    Other 104 13.5 ± 2.3 32 21.7 ± 6.4
Marital status
    Unmarried 201 17.9 ± 2.5 126 46.5 ± 5.2 <0.0001
    Married 772 76.0 ± 2.9 153 45.3 ± 4.7
    Missing3 34 – 10 –
Parity
    First birth 297 29.5 ± 2.7 58 17.0 ± 4.1 NS4
    Second birth or higher 635 63.2 ± 3.3 193 69.5 ± 5.6
    Missing 75 – 38 –
Trimester
    First 141 16.3 ± 2.2 97 44.4 ± 6.1 <0.01
    Second 372 34.7 ± 3.2 86 40.8 ± 5.3
    Third 370 32.9 ± 3.1 50 14.8 ± 3.7
    Missing 124 16.1 ± 2.6 56 25.7 ± 4.4
Health insurance
    No 130 9.4 ± 1.4 110 34.8 ± 4.3 <0.0001
    Yes 875 90.5 ± 1.4 173 63.8 ± 4.5
    Missing 2
– 
2 6
– 
2
Poverty-income ratio
    <1 286 15.2 ± 1.6 142 41.4 ± 6.7 <0.0001
    1–1.9 202 16.5 ± 2.4 76 21.2 ± 4.9
    ≥2 519 59.4 ± 3.4 71 29.1 ± 5.9
    Missing 70 25
Education
    High school or less 480 33.9 ± 2.9 231 75.5 ± 4.5 <0.0001
    Some college or more 526 66.0 ± 2.9 58 24.5 ± 4.5
    Missing 1 0
1Values are percentage ± SE based on weighted data.
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2
Denote unreliable estimates.
3
Missing denotes women who were missing data for the variable of interest.
4
P value ≥ 0.05.
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TABLE 2
Percentages of pregnant women taking dietary supplements and crude and adjusted prevalence ratios for the 
association between characteristics and supplement use in NHANES 1999–20061
Taking supplements Crude PR (95% CI) Model-adjusted PR (95% CI)
weighted %
Age
    <25 y 63.3 ± 4.5 Ref Ref
    ≥25 y 85.1 ± 2.4 1.34 (1.15, 1.57) 1.10 (0.97, 1.24)
Race/ethnicity
    Non-Hispanic white 88.6 ± 2.2 Ref Ref
    Non-Hispanic black 61.2 ± 4.1 0.69 (0.60, 0.79) 0.86 (0.73, 1.01)
    Mexican-American 63.1 ± 4.2 0.71 (0.62, 0.82) 0.90 (0.78, 1.02)
    Other 68.3 ± 7.0 0.77 (0.62, 0.95) 0.82 (0.66, 1.02)
Marital status
    Unmarried 57.0 ± 4.4 Ref Ref
    Married 85.3 ± 1.9 1.50 (1.27, 1.76) 1.11 (1.00, 1.24)
Parity
    First pregnancy 85.7 ± 3.2 Ref Ref
    Second pregnancy or more 75.9 ± 3.2 0.89 (0.79, 1.00) 0.93 (0.85, 1.02)
Trimester
    First trimester 63.0 ± 6.7 Ref Ref
    Second trimester 79.8 ± 3.5 1.27 (1.01, 1.59) 1.16 (0.99, 1.35)
    Third trimester 91.3 ± 2.2 1.45 (1.16, 1.82) 1.30 (1.11, 1.51)
Health insurance
    No 48.3 ± 4.8 Ref Ref
    Yes 83.0 ± 2.2 1.72 (1.41, 2.09) 1.11 (0.95, 1.30)
Poverty-income ratio
    <1.0 56.0 ± 6.0 Ref Ref
    1.0–1.9 72.9 ± 5.6 1.30 (0.97, 1.75) 2
    ≥2.0 87.6 ± 2.8 1.56 (1.25, 1.96) 2
Education
    High school or less 60.8 ± 3.7 Ref Ref
    Some college or more 90.3 ± 2.1 1.48 (1.31, 1.69) 1.17 (1.05, 1.30)
1Values are percentage ± SE and PR (95% CI) based on weighted data. Ref, reference group.
2Variable not in adjusted model.
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TABLE 3
Percentage of pregnant women taking supplements by supplement type and intakes of folic acid and iron 
supplementation among pregnant women in NHANES 1999–20061
Unweighted n Weighted %
Any folic acid-containing supplement 970 73.9 ± 2.6
Any iron-containing supplement 949 72.5 ± 2.5
Single vitamin 107 8.4 ± 1.5
Single mineral 183 11.1 ± 1.6
Multivitamin/mineral 962 74.7 ± 2.4
Antacid 301 28.4 ± 2.4
μg/d
Supplemental folic acid intake 761 817 ± 27.6
Supplemental iron intake2 754 47.7 ± 4.2
1Values are percentage ± SE or mean ± SE based on weighted data.
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TABLE 4
Percent of pregnant women taking a folic acid or iron-containing supplement by trimester of pregnancy in 
NHANES 1999–20061
Trimester Unweighted n Iron Folic acid
unweighted %
First 238 56.1 ± 6.7 60.0 ± 7.0
Second 458 76.4 ± 3.8 78.8 ± 3.5
Third 420 89.9 ± 2.3 89.2 ± 2.5
Missing2 180 56.4 ± 6.4 56.5 ± 6.4
1Values are percentage ± SE based on weighted data.
2
Missing denotes women who were missing information on month of pregnancy.
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TABLE 5
Percentiles of RBC folate by supplement use and trimester of pregnancy among pregnant women in NHANES 
1999–20061
RBC folate percentile
Unweighted n 2 10th 25th 50th 75th 90th
nmmol/L
Supplement users 935 1002 (887, 1111) 1360 (1257, 1442) 1628 (1589, 1695) 1968 (1849, 2096) 2420 (2226, 2968)
Supplement nonusers 269 622 (547, 792) 855 (704, 950) 1041 (962, 1184) 1359 (1191, 1540) 1905 (1521, 2590)
First trimester3 217 808 (725, 900) 953 (904, 1109) 1255 (1048, 1525) 1632 (1447, 1916) 2051 (1631, 2412)
Second trimester3 434 1015 (884, 1124) 1231 (1167, 1366) 1527 (1449, 1630) 1781 (1656, 1990) 2253 (1956, 2603)
Third trimester3 391 1146 (1079, 1331) 1467 (1400, 1600) 1773 (1694, 2012) 2159 (2019, 2301) 2536 (2297, 3815)
1
Percentile value (95% CI) based on weighted data.
2Unweighted sample size of pregnant women with measured RBC folate.
3
Includes both supplement users and nonusers.
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